08/05/2008
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding

07/22/2008
Xanodyne Receives Approvable Letter From the U.S. Food and Drug Administration for ZIPSOR™ (diclofenac potassium) Capsules

07/01/2008
Vertafore Announces Agreement to Acquire Sircon

[more news]